免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

临床试验

InsuLearn Feasibility With Type 1 Diabetes Patients Under MDI Therapy

NCT:NCT06411548 · COMPLETED

NCT编号NCT06411548
状态COMPLETED
开始日期2025-03-27
完成时间2025-10-17
SponsorUniversity of Virginia (OTHER)
First posted
Last updated

简要摘要

This is a 24-hour, randomized, crossover, single-center trial where participants are randomized to either start with the InsuLearn intervention or the usual care (UC) intervention. In the InsuLearn intervention, insulin doses are optimized using data collected in a 4-weeks at home data collection period.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态,请参阅官方记录。

↑